Saliva Collection Devices Diagnostics Market

Growing Prevalence of spine degeneration to boost market growth

The saliva collection and diagnostics market industry has grown tremendously over the past few years. Saliva plays an important role in the diagnosis of different diseases. In the early days, most diagnoses were painful and expensive blood tests, which were later replaced by more convenient options for saliva testing and diagnosis. Advances in the industry and field of saliva collection and diagnostics are supported by numerous publications that support various new applications of saliva. There are three methods of stimulating saliva volume collection: no stimulation, mechanical and acid stimulation.

These are the factors which enhance the saliva collection & diagnostics market CAGR across the globe in the recent years.

The saliva-based test is painless and precise. These tests are reliable ways to assess hormone levels in women. Over the past few years, blood tests have been used to measure female hormone levels. However, blood sampling is expensive, invasive and difficult to perform. Consequently, a major shift towards the adoption of cheaper and more convenient sample types has been witnessed. Saliva-based diagnostics are used to measure a variety of physiological conditions such as stress, depression, and sleep disturbances. These tests are also used in occupational health and sports medicine.

These factors are driving the growth of saliva collection & diagnostics market revenue.

Site of Collection: Secondary Research, Primary Research, MRFR Database and Analyst Review

The Global Global Saliva Collection and Diagnostics Market Industry is projected to experience substantial growth in the coming years. The market is expected to reach a valuation of 3.67 USD Billion in 2024, with a remarkable increase to 9.05 USD Billion by 2035. This growth trajectory indicates a compound annual growth rate of 8.56% from 2025 to 2035. Such projections reflect the increasing adoption of saliva-based diagnostics across various healthcare settings, driven by factors such as technological advancements, rising demand for non-invasive testing, and a growing focus on personalized medicine. These metrics underscore the market's potential and the opportunities it presents for stakeholders.

The Global Global Saliva Collection and Diagnostics Market Industry benefits from the increasing awareness surrounding oral health and its connection to systemic diseases. Research indicates that oral health is linked to various health conditions, including diabetes and cardiovascular diseases. This awareness drives the demand for saliva-based diagnostics, as they can provide insights into oral health and its implications for overall well-being. As public health initiatives promote oral health education, the market is likely to expand, reflecting a growing recognition of the importance of saliva testing in preventive healthcare. This trend may contribute to the market's growth trajectory towards 9.05 USD Billion by 2035.

The Global Global Saliva Collection and Diagnostics Market Industry experiences a notable increase in demand for non-invasive testing methods. Saliva collection is perceived as a less invasive alternative to blood sampling, appealing to both patients and healthcare providers. This trend is particularly evident in the growing interest in point-of-care testing, which enhances patient compliance and satisfaction. As of 2024, the market is valued at approximately 3.67 USD Billion, reflecting a shift towards more patient-friendly diagnostic solutions. The convenience of saliva collection is likely to drive further adoption, potentially leading to a market valuation of 9.05 USD Billion by 2035.

The Global Global Saliva Collection and Diagnostics Market Industry is significantly influenced by the rising emphasis on personalized medicine. Saliva testing allows for the analysis of genetic and biochemical markers, enabling tailored treatment plans for patients. This approach aligns with the broader trend towards individualized healthcare, where treatments are customized based on a patient's unique genetic profile. As healthcare systems worldwide adopt personalized medicine strategies, the demand for saliva-based diagnostics is expected to grow. This shift not only enhances patient outcomes but also contributes to the market's projected growth, with an anticipated valuation of 9.05 USD Billion by 2035.

Technological innovations play a crucial role in propelling the Global Global Saliva Collection and Diagnostics Market Industry forward. The development of advanced diagnostic tools, such as microfluidic devices and biosensors, enhances the accuracy and efficiency of saliva-based testing. These innovations enable rapid results and facilitate the detection of various diseases, including infectious and chronic conditions. As technology continues to evolve, it is anticipated that the market will witness a compound annual growth rate of 8.56% from 2025 to 2035. This growth underscores the importance of integrating cutting-edge technology into saliva diagnostics, thereby improving overall healthcare outcomes.

Regulatory bodies are increasingly recognizing the potential of saliva-based diagnostics, which positively impacts the Global Global Saliva Collection and Diagnostics Market Industry. Supportive regulations facilitate the approval and commercialization of saliva testing products, encouraging innovation and investment in this sector. Governments are likely to implement policies that promote the development of non-invasive diagnostic methods, thereby enhancing patient access to testing. This regulatory environment fosters a conducive atmosphere for market growth, potentially leading to a compound annual growth rate of 8.56% from 2025 to 2035. Such support is essential for the continued evolution of saliva diagnostics.

By Region, the study provides the market insights for saliva collection & diagnostics into North America, Europe, Asia-Pacific and Rest of the World. North America dominates the saliva testing devices market due to having the necessary funding to conduct research and develop new effective treatments through clinical trials. Furthermore, adoption of technologically advanced products and increasing number of regulatory agencies are driving the saliva collection devices market in North America to be the most lucrative.

Asia Pacific is expected to witness the largest market growth during the forecast period owing to rising awareness about easy and safe diagnosis of various diseases through several seminars and conferences held in the region.

Further, the major countries studied in the market report for saliva collection & diagnostics are: The U.S, Canada, Germany, France, UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.

Figure 3:  SALIVA COLLECTION & DIAGNOSTICS MARKET SHARE BY REGION 2022 (%)

Site of Collection: Secondary Research, Primary Research, MRFR Database and Analyst Review

Europe market of saliva collection & diagnostics accounts for the second-largest market share due to the regional market is segmented into Eastern Europe and Western Europe. The Western European market for saliva collection and diagnostics is segmented into the United Kingdom, Germany, France, Italy, Spain, and Rest of Europe. Government initiatives along with high number of people suffering from cancer are driving the market growth for saliva collection and diagnostics.

Moreover, The German market of saliva collection & diagnostics holds the largest market share, and the UK market of saliva collection & diagnostics is the fastest growing market in the European region.

The Asia Pacific market of Saliva Collection & Diagnostics is expected to grow at the fastest CAGR from 2024 to 2032. The Asia Pacific region is expected to witness the fastest growth rate owing to significant advancements in the field of diagnostic testing. According to a new study published in April 2022, India is witnessing the widespread adoption of home diagnostic tests and this trend is expected to increase in the coming years. People are adopting home-based diagnostic testing because it provides quick results at a lower cost. These factors are driving the demand for saliva testing in the region.

Furthermore, the China market of saliva collection & diagnostics holds the largest market share and Japan market of saliva collection & diagnostics is the fastest growing market in the region.

Major market players are investing heavily in research and development to increase their product lines, which will help the Saliva Collection & Diagnostics market to grow further. The market players have also undertaken a number of strategic initiatives to expand their footprints, including key market developments such as new product launches, contractual agreements, mergers and acquisitions, increasing investments, and collaborations with other organizations. Competitors in the Saliva Collection & Diagnostics industry must offer cost-effective products to expand and survive in the increasingly competitive and rising market environment.

One of the key business strategies adopted by the manufacturers in the Saliva Collection & Diagnostics industry to benefit their customers and expand their market segment is to manufacture locally to reduce operating costs. In recent years, the Saliva Collection & Diagnostics industry has provided some of the most significant benefits to medicine. Major players in the Saliva Collection & Diagnostics market such as Neogen Corporation. (US), SARSTEDT AG & Co. KG (Germany), Quest Diagnostics (US), OraSure Technologies (US) and Abbott Laboratories (US) are focusing on expanding the market demand by investing in research and development activities.

Headquartered in Michigan, USA, Neogen was founded in 1982. The company provides a broad range of solutions and services to the food processing, animal protein and agriculture industries, as well as the life sciences and toxicology sectors. The company has two business divisions, food safety and animal safety, of which animal safety is the market-focused department. The company offers products in categories such as animal safety, food safety, genomics, life sciences and toxicology, with toxicology being a category of market focus. The company is committed to the continuous development of saliva testing equipment.

In January 2020, NEOGEN Corporation announced that it had acquired Productos Quimicos Magiar, a distributor of the company's food safety diagnostic products, which will increase future sales and revenue.

Also, OraSure Technologies, Inc., headquartered in Pennsylvania, USA, develops, manufactures and distributes rapid diagnostic tests, sample collection and stabilization devices, and molecular service solutions designed to detect critical medical conditions. The company has two business segments, Diagnostics and Molecular Solutions, with Diagnostics being the market-focused segment. The company is engaged in the provision of products in categories such as diagnostics and test sampling tools, of which diagnostics and testing is the category that the market is focusing on. The company has initiated several strategic initiatives to expand its market.

In January 2021, DNA Genotek, a subsidiary of OraSure Technologies, Inc., announced that its product, named OMNIgene ORAL (OM-505) saliva collection kit, had been granted Emergency Use Authorization (EUA) to Ambry Genetics for Ambry COVID- 19 RT-PCR saliva test. This EUA grant received by the company increases its future sales and revenue.